<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727426</url>
  </required_header>
  <id_info>
    <org_study_id>215861071012</org_study_id>
    <nct_id>NCT02727426</nct_id>
  </id_info>
  <brief_title>Dietary Salt and Microvascular Function</brief_title>
  <official_title>Influence of High Salt Diet on Microvascular Reactivity in Young Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Josip Juraj Strossmayer University of Osijek</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Josip Juraj Strossmayer University of Osijek</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is well accepted that high-salt (HS) intake is an essential risk factor in development and
      progression of hypertension. Results of some recent studies suggest that some of the
      deleterious effects of a HS diet are independent of elevated blood pressure (BP) and may
      occur in normotensive individuals and are associated with impaired endothelial function.
      However, the effects of acute salt loading on endothelial function and vascular reactivity in
      young healthy individuals are still scarce and inconsistent.

      The purpose of present study is to determine whether one week of HS intake affects
      microvascular reactivity in young healthy subjects without changes in BP. In addition, the
      investigators sought to evaluate if potential HS diet-induced microvascular dysfunction is
      associated with changes in oxidative stress level and/or with modification of immunological
      response in young healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>microvascular reactivity</measure>
    <time_frame>two weeks after starting the protocol</time_frame>
    <description>Cutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperemia- PORH) and in response to iontophoresis of acetylcholine (ACh) (endothelium dependent vasodilation) before and after diet protocols.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxidative stress</measure>
    <time_frame>two weeks after starting the protocol</time_frame>
    <description>As direct indicator of oxidative stress, byproducts of lipid peroxidation - TBARS method (Thiobarbituric Acid Reactive Substances) with malondialdehyde (MDA) as standard (µM MDA) will be measured before and after LS and HS diet protocol (spectrophotometric method).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modification of immunological response by high salt diet</measure>
    <time_frame>two weeks after starting the protocol</time_frame>
    <description>Activated monocytes/macrophages and neutrophils will be measured by flow cytometry, with distinction of subpopulation of monocytes/macrophages (classical/nonclassical), their activation and the expression of the integrin LFA-1 (lymphocyte function-associated antigen 1) and VLA-4 (Very Late Antigen-4) - ligands VCAM-1 (vascular cell adhesion molecule 1 ) and ICAM-1 (vascular cell adhesion molecule 1).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>antioxidant capacity</measure>
    <time_frame>two weeks after starting the protocol</time_frame>
    <description>As an indicator of antioxidant capacity, the ferric reducing ability of plasma - the FRAP assay (Ferric reducing ability of plasma) with Trolox used as standard (mM Trolox) will be measured before and after LS and HS diet protocol (spectrophotometric method).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Salt; Excess</condition>
  <arm_group>
    <arm_group_label>low salt diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will be instructed to maintain a low-sodium (LS) diet, with an intake of less than 2.3 g of salt per day (DASH eating plan; US Department of Health and Human Services, 2006) for 7 days (washout period).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high salt diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After washout period, all subjects will be instructed to maintain a high-sodium (HS) diet, with an intake of 11.2 g of salt per day for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Salt (LS) diet</intervention_name>
    <description>Intake of less than 2.3 g of salt per day for 7 days.</description>
    <arm_group_label>low salt diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Salt (HS) diet</intervention_name>
    <description>Intake of 11.2 g of salt per day for 7 days.</description>
    <arm_group_label>high salt diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - healthy volunteers

        Exclusion Criteria:

          -  oral contraceptives

          -  drugs that could affect the endothelium

          -  hypertension

          -  coronary artery disease

          -  diabetes

          -  hyperlipidaemia

          -  renal impairment

          -  cerebrovascular and peripheral artery disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ines Drenjancevic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, University of Osijek, Croatia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana - Stupin, MD, PhD</last_name>
    <phone>+385915134958</phone>
    <email>anacavka@mefos.hr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ines - Drenjancevic, MD, PhD</last_name>
    <phone>+385912241406</phone>
    <email>ines.drenjancevic@mefos.hr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine Osijek, Laboratory for Clinical and Sport Physiology</name>
      <address>
        <city>Osijek</city>
        <zip>31000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Stupin, MD, PhD</last_name>
      <phone>'385915134598</phone>
      <email>anacavka@mefos.hr</email>
    </contact>
    <contact_backup>
      <last_name>Ines Drenjancevic, MD, PhD</last_name>
      <phone>'385912241406</phone>
      <email>ines.drenjancevic@mefos.hr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Cavka A, Cosic A, Jukic I, Jelakovic B, Lombard JH, Phillips SA, Seric V, Mihaljevic I, Drenjancevic I. The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans. J Physiol. 2015 Dec 15;593(24):5313-24. doi: 10.1113/JP271631. Epub 2015 Dec 7.</citation>
    <PMID>26498129</PMID>
  </reference>
  <reference>
    <citation>Cavka A, Cosic A, Grizelj I, Koller A, Jelaković B, Lombard JH, Phillips SA, Drenjancevic I. Effects of AT1 receptor blockade on plasma thromboxane A2 (TXA2) level and skin microcirculation in young healthy women on low salt diet. Kidney Blood Press Res. 2013;37(4-5):432-42. doi: 10.1159/000355723. Epub 2013 Oct 13.</citation>
    <PMID>24247418</PMID>
  </reference>
  <reference>
    <citation>Cavka A, Jukic I, Ali M, Goslawski M, Bian JT, Wang E, Drenjancevic I, Phillips SA. Short-term high salt intake reduces brachial artery and microvascular function in the absence of changes in blood pressure. J Hypertens. 2016 Apr;34(4):676-84. doi: 10.1097/HJH.0000000000000852.</citation>
    <PMID>26848993</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>April 3, 2016</last_update_submitted>
  <last_update_submitted_qc>April 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Josip Juraj Strossmayer University of Osijek</investigator_affiliation>
    <investigator_full_name>Ines Drenjancevic</investigator_full_name>
    <investigator_title>Vice Dean for Science, Faculty of Medicine Josip Juraj Strossmayer University of Osijek</investigator_title>
  </responsible_party>
  <keyword>microvascular function</keyword>
  <keyword>laser Doppler flowmetry</keyword>
  <keyword>high salt diet</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

